Ju-Qiong Wang

712 total citations
8 papers, 513 citations indexed

About

Ju-Qiong Wang is a scholar working on Surgery, Molecular Biology and Biochemistry. According to data from OpenAlex, Ju-Qiong Wang has authored 8 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Biochemistry. Recurrent topics in Ju-Qiong Wang's work include Cholesterol and Lipid Metabolism (3 papers), Lipid metabolism and biosynthesis (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Ju-Qiong Wang is often cited by papers focused on Cholesterol and Lipid Metabolism (3 papers), Lipid metabolism and biosynthesis (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Ju-Qiong Wang collaborates with scholars based in China and South Korea. Ju-Qiong Wang's co-authors include Jie Luo, Bao‐Liang Song, Xiongjie Shi, Xiaolu Zhao, Xiao-Yi Lu, Ao Hu, Wei Qi, Yunfeng Li, Wei Jiang and Yi Ding and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Ju-Qiong Wang

8 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju-Qiong Wang China 8 244 149 103 102 88 8 513
Khrystyna Platko Canada 14 253 1.0× 172 1.2× 137 1.3× 89 0.9× 87 1.0× 19 561
Asami Hagiwara Japan 5 381 1.6× 97 0.7× 113 1.1× 107 1.0× 64 0.7× 8 562
Akira Takaguri Japan 13 217 0.9× 119 0.8× 65 0.6× 76 0.7× 58 0.7× 34 500
Pia Stillemark-Billton Sweden 9 263 1.1× 116 0.8× 98 1.0× 100 1.0× 129 1.5× 11 570
Mingzhu Tang China 11 329 1.3× 105 0.7× 153 1.5× 170 1.7× 50 0.6× 22 685
Shuichi Nagashima Japan 15 251 1.0× 204 1.4× 95 0.9× 79 0.8× 33 0.4× 37 562
Boris B. Boyanovsky United States 14 461 1.9× 234 1.6× 105 1.0× 107 1.0× 95 1.1× 24 786
Lakshman Segar United States 13 283 1.2× 95 0.6× 100 1.0× 60 0.6× 33 0.4× 19 520
Ainara G. Cabodevilla United States 7 232 1.0× 62 0.4× 124 1.2× 109 1.1× 59 0.7× 14 492
Jerry Angdisen United States 12 300 1.2× 187 1.3× 161 1.6× 73 0.7× 42 0.5× 23 583

Countries citing papers authored by Ju-Qiong Wang

Since Specialization
Citations

This map shows the geographic impact of Ju-Qiong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju-Qiong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju-Qiong Wang more than expected).

Fields of papers citing papers by Ju-Qiong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju-Qiong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju-Qiong Wang. The network helps show where Ju-Qiong Wang may publish in the future.

Co-authorship network of co-authors of Ju-Qiong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ju-Qiong Wang. A scholar is included among the top collaborators of Ju-Qiong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju-Qiong Wang. Ju-Qiong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Meng, Fanhua, Shuai Liu, Jian Xiao, et al.. (2023). New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol. Arteriosclerosis Thrombosis and Vascular Biology. 43(7). 1219–1233. 17 indexed citations
2.
Wang, Ju-Qiong, Ao Hu, Gang Deng, et al.. (2022). Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion. Nature. 608(7922). 413–420. 104 indexed citations
3.
Wang, Ju-Qiong, et al.. (2020). SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1. Journal of Biological Chemistry. 296. 100032–100032. 17 indexed citations
4.
Xiao, Jian, Ju-Qiong Wang, Xiongjie Shi, et al.. (2020). POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation. Protein & Cell. 12(4). 279–296. 39 indexed citations
5.
Li, Yunfeng, et al.. (2020). Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease. PLoS Genetics. 16(8). e1008955–e1008955. 45 indexed citations
6.
Lu, Xiao-Yi, Xiongjie Shi, Ao Hu, et al.. (2020). Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis. Nature. 588(7838). 479–484. 188 indexed citations
7.
Li, Yunfeng, Jie Luo, Jiqiu Wang, et al.. (2019). Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance. Nature Metabolism. 1(5). 570–583. 68 indexed citations
8.
Wei, Jian, Yingyu Zhang, Jie Luo, et al.. (2017). The GARP Complex Is Involved in Intracellular Cholesterol Transport via Targeting NPC2 to Lysosomes. Cell Reports. 19(13). 2823–2835. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026